Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
This win is on the back of a prestigious order from Reliance Life Sciences
The product will be manufactured at Lupin's facility in Nagpur, India.
The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital
Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and frequency
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
Subscribe To Our Newsletter & Stay Updated